Response to letter to the editor from Viola et al: "calcifediol treatment and COVID-19-related outcomes"
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Nogués Solan, Francesc Xavier
- dc.contributor.author Quesada-Gómez, J.M.
- dc.contributor.author García-Giralt, Natalia
- dc.date.accessioned 2022-09-07T06:38:41Z
- dc.date.issued 2021
- dc.format.mimetype application/pdf
- dc.identifier.citation Nogués X, Quesada-Gomez JM, Garcia-Giralt N. Response to letter to the editor from Viola et al: "calcifediol treatment and COVID-19-related outcomes". J Clin Endocrinol Metab. 2021 Nov 19; 106(12): e5281-2. DOI: 10.1210/clinem/dgab566.
- dc.identifier.doi http://dx.doi.org/10.1210/clinem/dgab566
- dc.identifier.issn 0021-972X
- dc.identifier.uri http://hdl.handle.net/10230/54012
- dc.language.iso eng
- dc.publisher Oxford University Press
- dc.rights © Oxford University Press. This is a pre-copyedited, author-produced version of an article accepted for publication in The Journal of clinical endocrinology and metabolism following peer review. The version of record Nogues X, Quesada-Gomez JM, Garcia-Giralt N. Response to letter to the editor from Viola et al: "calcifediol treatment and COVID-19-related outcomes". J Clin Endocrinol Metab. 2021 Nov 19; 106(12): e5281-2, is available online at: https://academic.oup.com/jcem/article/106/12/e5281/6333153?login=true.
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.subject.other COVID-19 (Malaltia) -- Tractament
- dc.title Response to letter to the editor from Viola et al: "calcifediol treatment and COVID-19-related outcomes"
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/acceptedVersion